The Economic Foundations of the Georgia-Pacific Factors in Reasonable Royalty Analysis

In patent infringement litigation, when the patentee cannot prove entitlement to lost profits — or when such profits do not capture the full measure of the harm — a reasonable royalty serves as the default measure of compensatory damages. The guiding framework for determining this royalty was set forth in Georgia-Pacific Corp. v. United States Plywood Corp., 318 F. Supp. 1116 (S.D.N.Y. 1970), which enumerated fifteen factors intended to simulate the outcome of a hypothetical negotiation between a willing licensor and licensee at the time of first infringement.

Though widely cited, the Georgia-Pacific (GP) factors are often applied mechanically, or reduced to a checklist. Yet behind each factor lies an important economic principle. A rigorous damages analysis requires not only a recitation of the factors but a careful integration of their economic content. This article provides an overview of the economic logic underpinning the GP framework, focusing on how each factor contributes to a coherent valuation of patent rights.

At its core, the reasonable royalty standard seeks to replicate the outcome of a hypothetical bargaining process under conditions that, while fictional, must be grounded in market realities. The negotiation is presumed to take place between a willing licensor and a willing licensee, both operating at arm's length and with full knowledge of the patent's value and enforceability. This construct requires the economist to step into a "but-for" world and evaluate what price the parties would have agreed upon to license the patented technology, absent infringement.

The first two GP factors — the rates paid by the licensee and others for use of the patented invention — invoke the principle of market comparables. These factors mirror the valuation approaches used in transfer pricing, IP licensing, and business valuation more broadly. Prior licenses can be informative, but only if they are economically comparable: involving similar technologies, similarly situated parties, and negotiated under circumstances free from litigation pressure or settlement motives. The economist must carefully assess whether these transactions reflect arm's-length valuation or are distorted by strategic considerations.

Factors 3 through 5 address the nature and scope of the license, including exclusivity, territorial restrictions, and the extent of use. These terms shape the value of the licensed rights and thus must be reflected in the royalty rate. An exclusive license that covers all fields of use and all territories is inherently more valuable than a narrow, non-exclusive one. These factors correspond to the economic concept of option value — the broader the rights granted, the more future value is conveyed to the licensee.

Factor 6 — whether the licensor and licensee are competitors — relates to opportunity cost and strategic substitution. When the parties are market rivals, the licensor may demand a premium to compensate for lost competitive advantage. This reflects the economic cost of enabling a competitor to access proprietary technology and is analogous to the "make-or-buy" decision in industrial organization theory.

Factors 7 and 8 pertain to the commercial success and profitability of products embodying the invention. Here the focus shifts to the downstream value created by the patented technology. Economically, this aligns with value-based pricing: the royalty should reflect not just the cost of developing the technology, but the value it creates for the licensee. High margins or dominant market share can justify higher royalty rates, provided that the patented feature is a material contributor to that success.

Factors 9 and 10 concern the utility and advantages of the invention over prior art, as well as the nature of the patented invention. These relate directly to incremental benefit — the economic value added by the patented feature relative to available alternatives. This concept is central in both conjoint analysis and cost-benefit valuation. A patent that offers a unique, non-substitutable improvement commands a higher royalty than one offering marginal gains.

Factor 11 reflects the extent to which the infringer has made use of the invention, an application of usage-based valuation. Greater reliance on the patented feature — whether in terms of unit volumes, system integration, or marketing emphasis — typically justifies a higher royalty. This factor also captures real options logic: the more embedded the invention is in the infringer's operations, the greater its replacement cost, and the higher its ex post bargaining value.

Factor 12 concerns the profit margins attributable to the invention. While distinct from lost profits, this factor reflects profit-splitting theory — how the surplus created by the patented invention is divided between licensor and licensee. Economic methods such as Nash bargaining or Shapley value decomposition can provide formal tools to implement this reasoning, particularly when the patent is one component in a complex product.

Factor 13 involves the portion of realizable profit attributable to the patented invention as distinguished from other factors. This is where the principle of apportionment is directly addressed. In multi-component products, the royalty must reflect the economic contribution of the patented feature, not the entire value of the product. This calls for analytical tools such as regression analysis, consumer preference modeling, or feature-specific cost savings to isolate the patent's share of value.

Factor 14 addresses expert testimony, reinforcing the need for economic analysis that is not only logical but empirically grounded. Factor 15, a catch-all for any other relevant economic considerations, serves as a reminder that royalty analysis must be context-specific and responsive to the factual record.

Importantly, the GP factors are not a formula but a framework. Their weight and relevance vary by case, and the economist's task is to integrate them into a coherent economic narrative. This involves reconciling conflicting indicators (e.g., high commercial success but low comparables), addressing the implications of licensing practices, and incorporating assumptions consistent with both liability findings and market evidence.

In conclusion, the Georgia-Pacific framework provides a flexible but analytically rich set of inputs for determining a reasonable royalty. When interpreted through the lens of economic theory — market comparables, value creation, cost allocation, profit-sharing, and strategic behavior — it becomes more than a list of factors: it becomes a disciplined method for estimating the price that rational actors would have paid to license innovation, under fair and informed conditions.